Sintez awarded the Platinum Ounce
The company has been awarded in two categories of the pharmaceutical award
On 4 June, the Sintez Kurgan Pharmaceutical Plant (part of Sistema JSFC) was recognised as the winner of the 20th Platinum Ounce All-Russia open competition in two categories: "Dynamics of the year" for high performance in the commercial segment and "Advertising marketing campaign of the year" for Angiorus medicine promotion. The award ceremony was held as an online broadcast.
“People are the main value of any company. For two years, we have been creating a team of leaders and professionals”, said Sergey Klykov, CEO of Pharm-Center JSC (the managing company of Sintez OJSC). “In 2019, the company achieved significant revenue growth (up to RUB 10.6 bn), record-breaking production volumes and success in the commercial segment, which have not gone unnoticed by the pharmaceutical community."
Sintez received the first award for its record-breaking growth on the Russian retail market in 2019 (+46%), and the second one – for its creative Angiorus marketing campaign. During the ceremony, Rustem Muratov, President of Sintez OJSC, noted that the company was receiving the Platinum Ounce award for the first time. “The company has won these awards owing to our team and our partners; I want to thank them all. We are very pleased that our joint efforts have been highly appreciated by the pharmaceutical community! Angiorus has been promoted simultaneously on the Internet, in pharmacies and pharmacy chains. The retail market share of venotonic Angiorus has quadrupled over the year; it is the most dynamically developing brand in its category.”
Let us recall that the Platinum Ounce open competition among professionals is considered the most significant and prestigious competition in the pharmaceutical industry. The winners are decided by the Expert Council, which includes about 100 representatives of the pharmaceutical industry, including the IQVIA, DSM Group, Ipsos Healthcare and AlphaRM analytical companies, as well as the information and analytical Pharmaceutical Bulletin.
Sistema JSFC, together with Nacimbio JSC, which is part of Rostec State Corporation, are the shareholders in Sintez OJSC.